FDA Panel: Argus II Artificial Retina’s Benefits Outweigh Risks

Second Sight Medical Products gains FDA panel endorsement for humanitarian device exemption approval of Argus II, which would be the first artificial retina available to restore vision to the blind.

More from Regulation

More from Policy & Regulation